세계의 글리코믹스 또는 글리코바이올로지 시장 보고서(2025년)

Glycomics or Glycobiology Global Market Report 2025

US $ 4,490 ￦ 6,496,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,390,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,284,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

글리코믹스 또는 글리코바이올로지 시장 규모는 향후 수년간 급성장할 것으로 예상됩니다. 2029년에는 CAGR 17.2%로 40억 3,000만 달러로 성장할 전망입니다. 예측기간의 성장은 글리칸에 특화된 인공지능(AI)과 데이터 분석, 글리코바이올로지를 기반으로 한 의약품 개발의 확대, 질환 바이오마커 탐색에서의 글리코믹스의 통합, 맞춤형 의료, 글리칸을 기반으로 한 치료법에 기인합니다. 예측 기간의 주요 동향으로는 분야 간 공동 연구, 질병 메커니즘에서의 글리코실화 패턴, 혁신적인 정밀의료 및 개인화 치료, 해당 분석 도구의 진보, 면역요법 및 백신에서의 글리칸 등이 있습니다.

심각한 만성 질환에 대응하는 의약품 수요 급증은 글리코믹스 또는 글리코바이올로지 시장의 성장을 가속할 전망입니다. 만성 질환은 결정적인 치료법 없이 장기간 지속되기 때문에 이러한 질병에 대한 약물 개발에서 당 사슬의 변화와 그 기능적 의미를 이해하기 위해 글리코믹스에 대한 광범위한 조사가 필요합니다. 미국암협회의 Cancer Facts and Figures 2022-2024에 따르면 만성질환으로 여겨지는 암 생존자 수는 2032년 2,250만명에서 2040년에는 약 2,600만 명으로 증가할 것으로 예측되고 있습니다. 따라서 심각한 만성 질환의 치료제에 대한 수요 증가는 글리코믹스 또는 글리코바이올로지 시장의 중요한 촉진요인이 되고 있습니다.

의약품에 대한 요구 증가는 글리코믹스 또는 글리코바이올로지 시장 성장의 주요 촉진요인이 될 것으로 예상됩니다. 이 제품에는 다양한 질병 상태를 진단, 예방, 치료 및 치유하기 위해 특별히 처방된 의약품이 포함됩니다. 글리코믹스 또는 글리코바이올로지는 질병 메커니즘의 해명, 치료 표적의 식별, 약물 설계 및 효과의 최적화 등 의약품 개발에 중요한 역할을 합니다. 유럽제약단체연합회(EFPIA)에 따르면 2022년 유럽의 의약품 총생산액은 3,842억 달러(3,400억 유로)로 급증했고, 전년도 3,662억 6,700만 달러(3,239억 5,000만 유로)에서 4.95% 증가한 수치입니다. 의약품에 대한 수요 증가가 글리코믹스 또는 글리코바이올로지시장의 성장을 뒷받침하는 촉매로서 기능하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 글리코믹스 또는 글리코바이올로지 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업의 분석
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 성장률 분석
• 세계의 글리코믹스 또는 글리코바이올로지 시장 실적: 규모와 성장, 2019-2024년
• 세계의 글리코믹스 또는 글리코바이올로지 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 글리코믹스 또는 글리코바이올로지 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 효소
• 키트
• 시약 및 화학약품
• 기기
• 탄수화물
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약물 발견 및 개발
• 질병의 진단
• 기타
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 학술연구기관
• 제약 및 바이오테크놀러지 기업
• 임상 실험실
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 효소의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 글리코시다제
• 글리코실트랜스퍼라제
• 시알리다제
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 키트의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 글리칸 분석 키트
• 글리코바이올로지 연구 키트
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 시약 및 화학약품의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 단당류
• 올리고당
• 화학수식제
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 기기의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 질량 분석계
• 크로마토그래피 시스템
• 이미지 시스템
• 세계의 글리코믹스 또는 글리코바이올로지 시장 : 탄수화물의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 천연 탄수화물
• 합성 탄수화물

제7장 지역별,국가별 분석

• 세계의 글리코믹스 또는 당쇄 생물학 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 글리코믹스 또는 당쇄 생물학 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 글리코믹스 또는 글리코바이올로지 시장 : 경쟁 구도
• 글리코믹스 또는 글리코바이올로지 시장 : 기업 프로파일
  • Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
  • New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Shimadzu Corporation
• ProZyme Inc.
• Takara Bio Inc.
• Asparia Glycomics SL
• Lectenz Bio
• Chemily Glycoscience LLC
• Z Biotech LLC
• RayBiotech Inc.
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Bio-Techne Corp.
• AMS Bio LLC
• Ludger Ltd.
• CD BioGlyco Ltd.
• GlycoDiag SAS

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 글리코믹스 또는 글리코바이올로지 시장 2029년: 새로운 기회를 제공하는 국가
• 글리코믹스 또는 글리코바이올로지 시장 2029년: 새로운 기회를 제공하는 부문
• 글리코믹스 또는 글리코바이올로지 시장 2029년: 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (ai) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine, and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In October 2022, the Centre for Cellular and Molecular Platforms (C-CAMP), an India-based research foundation, entered into a partnership with Agilent Technologies, Inc. for an undisclosed amount. Through this collaboration, C-CAMP aims to enhance its portfolio by leveraging Agilent's expertise in mass spectrometry-based characterization of biotherapeutics and biosimilars. Agilent Technologies Inc., a US-based company, is known for offering AdvanceBio glycoenzymes.

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glycomics or Glycobiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
• 2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
• 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories
• Subsegments:
• 1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
• 2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
• 3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
• 4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
• 5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates
• Companies Mentioned: Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Glycomics or Glycobiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Glycomics or Glycobiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Glycomics or Glycobiology Market Growth Rate Analysis
• 5.4. Global Glycomics or Glycobiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Glycomics or Glycobiology Total Addressable Market (TAM)

6. Glycomics or Glycobiology Market Segmentation

• 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Kits
• Reagents and Chemicals
• Instruments
• Carbohydrates
• 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery and Development
• Disease Diagnostics
• Other Applications
• 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• 6.4. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycosidases
• Glycosyltransferases
• Sialidases
• 6.5. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycan Analysis Kits
• Glycobiology Research Kits
• 6.6. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Reagents And Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monosaccharides
• Oligosaccharides
• Chemical Modifiers
• 6.7. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectrometers
• Chromatography Systems
• Imaging Systems
• 6.8. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Carbohydrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Carbohydrates
• Synthetic Carbohydrates

7. Glycomics or Glycobiology Market Regional And Country Analysis

• 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

• 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glycomics or Glycobiology Market

• 9.1. China Glycomics or Glycobiology Market Overview
• 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glycomics or Glycobiology Market

• 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glycomics or Glycobiology Market

• 11.1. Japan Glycomics or Glycobiology Market Overview
• 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glycomics or Glycobiology Market

• 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

• 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glycomics or Glycobiology Market

• 14.1. South Korea Glycomics or Glycobiology Market Overview
• 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

• 15.1. Western Europe Glycomics or Glycobiology Market Overview
• 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glycomics or Glycobiology Market

• 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glycomics or Glycobiology Market

• 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glycomics or Glycobiology Market

• 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glycomics or Glycobiology Market

• 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glycomics or Glycobiology Market

• 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

• 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
• 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glycomics or Glycobiology Market

• 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glycomics or Glycobiology Market

• 23.1. North America Glycomics or Glycobiology Market Overview
• 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glycomics or Glycobiology Market

• 24.1. USA Glycomics or Glycobiology Market Overview
• 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glycomics or Glycobiology Market

• 25.1. Canada Glycomics or Glycobiology Market Overview
• 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glycomics or Glycobiology Market

• 26.1. South America Glycomics or Glycobiology Market Overview
• 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glycomics or Glycobiology Market

• 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glycomics or Glycobiology Market

• 28.1. Middle East Glycomics or Glycobiology Market Overview
• 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glycomics or Glycobiology Market

• 29.1. Africa Glycomics or Glycobiology Market Overview
• 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

• 30.1. Glycomics or Glycobiology Market Competitive Landscape
• 30.2. Glycomics or Glycobiology Market Company Profiles
  • 30.2.1. Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Glycomics or Glycobiology Market Other Major And Innovative Companies

• 31.1. Shimadzu Corporation
• 31.2. ProZyme Inc.
• 31.3. Takara Bio Inc.
• 31.4. Asparia Glycomics SL
• 31.5. Lectenz Bio
• 31.6. Chemily Glycoscience LLC
• 31.7. Z Biotech LLC
• 31.8. RayBiotech Inc.
• 31.9. Thermo Fisher Scientific Inc.
• 31.10. Promega Corporation
• 31.11. Bio-Techne Corp.
• 31.12. AMS Bio LLC
• 31.13. Ludger Ltd.
• 31.14. CD BioGlyco Ltd.
• 31.15. GlycoDiag SAS

32. Global Glycomics or Glycobiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Recent Developments In The Glycomics or Glycobiology Market

35. Glycomics or Glycobiology Market High Potential Countries, Segments and Strategies

• 35.1 Glycomics or Glycobiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Glycomics or Glycobiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Glycomics or Glycobiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료